Gluten-free ice cream cookie sandwiches recalled for Listeria
Groove gluten-free ice cream cookie sandwiches are being recalled by Great Feeling Foods, LLC because of possible contamination with Listeria monocytogenes. The ice cream has a custard base made by Snoqualmie Gourmet Ice Cream that could be contaminated. Consumers are encouraged to either throw away the products or return them to the stores for a refund.
Great Feeling Foods, LLC is recalling Groove gluten-free ice cream cookie sandwiches that were made between May 16, 2014 and December 20, 2014. This includes Groove gluten-free chocolate chip cookie & French vanilla ice cream sandwiches, Groove gluten-free dark chocolate cookie & French vanilla ice cream sandwiches, Groove gluten-free oatmeal raisin cookie & French vanilla ice cream sandwiches, Groove gluten free peanut butter cookie & French vanilla ice cream sandwiches, Groove gluten free dark chocolate cookie & French chocolate ice cream sandwiches and Groove gluten-free peanut butter cookie & French chocolate ice cream sandwiches.
The ice cream was sold in packages of 3 and 6 ounces with lot codes that end in 14. The recalled best by dates include 010715, 041715, 050915, 071115, 072215, 081215, 081915 and 092415. The company believes distribution of the recalled ice cream was limited to Oregon and Washington. Listeria monocytogenes can lead to a serious infection that may be fatal for some people. The symptoms include nausea, cramping, diarrhea, fever and headaches. This type of infection is especially dangerous for pregnant women who may suffer a miscarriage.
If you have the recalled product, then it is important to dispose of it immediately. You may also be able to get a refund from the store, and Great Feeling Foods, LLC encourages consumers to call them at 503-329-2750 with any questions. Snoqualmie Gourmet Ice Cream, Inc. began the alert process and notified the company about issues with the ice cream custard base.
Read more about celiac disease:
Gluten-free gift ideas for celiac disease sufferers
Researchers work on new celiac disease medications